Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Paclitaxel by DAE HWA Pharmaceutical for Metastatic Breast Cancer: Likelihood of Approval
Paclitaxel is under clinical development by DAE HWA Pharmaceutical and currently in Phase II for Metastatic Breast Cancer. According to...
Paclitaxel by DAE HWA Pharmaceutical for Kaposi Sarcoma: Likelihood of Approval
Paclitaxel is under clinical development by DAE HWA Pharmaceutical and currently in Phase I for Kaposi Sarcoma. According to GlobalData,...
Paclitaxel by DAE HWA Pharmaceutical for Lung Cancer: Likelihood of Approval
Paclitaxel is under clinical development by DAE HWA Pharmaceutical and currently in Phase I for Lung Cancer. According to GlobalData,...
Paclitaxel by DAE HWA Pharmaceutical for Ovarian Cancer: Likelihood of Approval
Paclitaxel is under clinical development by DAE HWA Pharmaceutical and currently in Phase I for Ovarian Cancer. According to GlobalData,...
Paclitaxel by DAE HWA Pharmaceutical for Cervical Cancer: Likelihood of Approval
Paclitaxel is under clinical development by DAE HWA Pharmaceutical and currently in Phase I for Cervical Cancer. According to GlobalData,...
Paclitaxel by DAE HWA Pharmaceutical for Head And Neck Cancer: Likelihood of Approval
Paclitaxel is under clinical development by DAE HWA Pharmaceutical and currently in Phase I for Head And Neck Cancer. According...
Paclitaxel by DAE HWA Pharmaceutical for Bladder Cancer: Likelihood of Approval
Paclitaxel is under clinical development by DAE HWA Pharmaceutical and currently in Phase I for Bladder Cancer. According to GlobalData,...
Paclitaxel by DAE HWA Pharmaceutical for Angiosarcoma: Likelihood of Approval
Paclitaxel is under clinical development by DAE HWA Pharmaceutical and currently in Phase I for Angiosarcoma. According to GlobalData, Phase...
Paclitaxel by DAE HWA Pharmaceutical for Metastatic Breast Cancer: Likelihood of Approval
Paclitaxel is under clinical development by DAE HWA Pharmaceutical and currently in Phase II for Metastatic Breast Cancer. According to...